Nektar Therapeutics
NKTR
$1.24
Share price
-6.06%
Change (1 day)
33.33%
Change (1 year)
Categories
Earnings for Nektar Therapeutics (NKTR)
Earnings in 2023 (TTM): -$0.28 B
According to Nektar Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.28 B. In 2022 the company made an earning of -$0.37 B an increase over its 2021 earnings that were of -$0.53 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Nektar Therapeutics from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.28 B | -24.31% |
| 2022 | -$0.37 B | -30.25% |
| 2021 | -$0.53 B | 17.87% |
| 2020 | -$0.45 B | 0.88% |
| 2019 | -$0.45 B | -164.46% |
| 2018 | $0.68 B | -810.61% |
| 2017 | -$96.08 M | -37.06% |
| 2016 | -$0.16 B | 89.22% |
| 2015 | -$80.68 M | 48.22% |
| 2014 | -$54.43 M | -65.93% |
| 2013 | -$0.16 B | -6.81% |
| 2012 | -$0.18 B | 28.95% |
| 2011 | -$0.14 B | 258.8% |
| 2010 | -$37.06 M | -63.94% |
| 2009 | -$0.11 B | -392.45% |
| 2008 | $35.14 M | -211.74% |
| 2007 | -$31.46 M | -79.57% |
| 2006 | -$0.16 B | -16.9% |
| 2005 | -$0.19 B | 81.53% |
| 2004 | -$0.11 B | 54.19% |
| 2003 | -$66.19 M | -33.87% |
| 2002 | -$0.11 B | -9.6% |
| 2001 | -$0.12 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -6,243.58% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -1,282.60% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | -2,943.38% | 🇺🇸 USA |
 Baxter BAX | -$47 M | -82.99% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -1,198.62% | 🇺🇸 USA |
 AstraZeneca AZN | $8.49 B | -3,175.05% | 🇬🇧 UK |
 Richardson Electronics RELL | $8.84 M | -103.20% | 🇺🇸 USA |
 Alkermes ALKS | $0.44 B | -260.92% | 🇮🇪 Ireland |